Muutke küpsiste eelistusi

Kidney Cancer: Recent Results of Basic and Clinical Research [Kõva köide]

Edited by , Series edited by
  • Formaat: Hardback, 130 pages, kaal: 430 g, 45 fig., 6 in color, 10 tab.; 45 Illustrations
  • Sari: Contributions to Nephrology 128
  • Ilmumisaeg: 04-Oct-1999
  • Kirjastus: S Karger AG
  • ISBN-10: 380556919X
  • ISBN-13: 9783805569194
Teised raamatud teemal:
  • Formaat: Hardback, 130 pages, kaal: 430 g, 45 fig., 6 in color, 10 tab.; 45 Illustrations
  • Sari: Contributions to Nephrology 128
  • Ilmumisaeg: 04-Oct-1999
  • Kirjastus: S Karger AG
  • ISBN-10: 380556919X
  • ISBN-13: 9783805569194
Teised raamatud teemal:
Cancer is above all a heritable disorder of somatic cells and gene expression, but environment is also involved in its origin. Hereditary kidney cancer should prove valuable to understand the mechanisms of disease and to the development of therapeutic measures. Recently, scientists have succeeded in cloning and identifying the genes responsible for the following familial kidney cancers: von Hippel-Lindau disease, papillary renal cell carcinoma, tuberous sclerosis and Wilms tumor (all autosomal dominant). This book brings together some of the most recent advances made with respect to kidney cancers: Leading investigators present recent results on VHL, MET, TSC1 and TSC2 and WT1 genes, among others, as well as on environmentally induced kidney cancers (caused by long-term hemodialysis or induced chemically) and their treatments (surgery and gene therapy), providing an excellent survey of this field. This publication will be of interest to both researchers and clinicians concerned with cancer of the kidney.
Germline and somatic mutations in von Hippel-Lindau disease gene and its
significance in the development of kidney cancer; hereditary papillary renal
carcinoma - pathology and pathogenesis; renal cell carcinomas in patients on
long-term hemodialysis; TSC1 and TSC2 gene mutations in human kidney tumours;
classification of renal cell cancer based on (cyto)genetic analysis; Wilms'
tumour and the WT1 gene; gene-modified immunotherapy for renal cell
carcinoma; Wilms' tumour (nephroblastoma); pathogenesis of renal cell
adenomas and carcinomas in animal models.